CINECA IRIS Institutional Research Information System

CORSO, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.960
EU - Europa 1.544
AS - Asia 843
SA - Sud America 24
OC - Oceania 19
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.404
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.928
CN - Cina 550
IT - Italia 510
IE - Irlanda 185
SE - Svezia 164
DE - Germania 155
FR - Francia 127
UA - Ucraina 84
FI - Finlandia 75
GB - Regno Unito 66
KR - Corea 66
PL - Polonia 51
JP - Giappone 50
VN - Vietnam 45
SG - Singapore 41
NL - Olanda 37
IN - India 30
CA - Canada 23
BE - Belgio 21
AT - Austria 14
AU - Australia 14
ES - Italia 11
HK - Hong Kong 11
IR - Iran 11
TW - Taiwan 11
PT - Portogallo 9
BR - Brasile 8
RU - Federazione Russa 8
TR - Turchia 8
CL - Cile 7
CH - Svizzera 6
IL - Israele 6
GR - Grecia 5
KE - Kenya 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
GT - Guatemala 4
LK - Sri Lanka 3
MX - Messico 3
PE - Perù 3
SN - Senegal 3
TH - Thailandia 3
CO - Colombia 2
DK - Danimarca 2
EU - Europa 2
HU - Ungheria 2
MY - Malesia 2
RO - Romania 2
SI - Slovenia 2
AM - Armenia 1
AR - Argentina 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
GH - Ghana 1
IM - Isola di Man 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MM - Myanmar 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 5.404
Salva come PNG Salva come JPEG
Città #
Chandler 327
Ann Arbor 313
Houston 267
Fairfield 266
Beijing 206
Dublin 185
Woodbridge 140
Ashburn 106
Wilmington 104
Seattle 100
Cambridge 99
Torino 85
Nyköping 74
Dearborn 67
Villeurbanne 63
Jacksonville 53
Medford 53
Princeton 52
Pisa 50
Warsaw 47
Turin 41
Milan 40
Shanghai 37
Nanjing 36
Guangzhou 31
Dong Ket 28
New York 28
Redwood City 27
Hangzhou 25
Boston 24
Groningen 22
San Diego 20
Brussels 17
Fremont 14
Vienna 14
Los Angeles 13
Tokyo 13
Boardman 12
Florence 12
Carrara 11
Jinan 11
Rome 11
Zhengzhou 11
Munich 10
Chengdu 9
Hefei 9
London 9
Mumbai 9
Seoul 9
Singapore 9
Genoa 8
Kunming 8
Verona 8
Wuhan 8
Changsha 7
Hebei 7
Nanchang 7
Norwalk 7
Ottawa 7
Upper Marlboro 7
Amsterdam 6
Falls Church 6
San Antonio 6
San Jose 6
Silver Spring 6
Taipei 6
Barcelona 5
Helsinki 5
Paris 5
Salerno 5
San Mateo 5
Varese 5
Washington 5
Chongqing 4
Delhi 4
Duncan 4
Eitensheim 4
Gainesville 4
Norwich 4
Nürnberg 4
Phoenix 4
Rajkot 4
Reston 4
Tampa 4
Temuco 4
Tianjin 4
Trento 4
Tuglie 4
Xian 4
Banqiao 3
Bethesda 3
Brescia 3
Buffalo 3
Cagliari 3
Caluire-et-Cuire 3
Chuo 3
Farnborough 3
Fontenay-sous-bois 3
Gangnam-gu 3
Guatemala City 3
Totale 3.461
Salva come PNG Salva come JPEG
Nome #
How Can Gastric Cancer Molecular Profiling Guide Future Therapies? 386
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 275
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer. 262
Enhanced c-Met activity promotes G-CSF induced mobilization of hematopoietic progenitor cells via ROS signaling. 238
Only a subset of Met-activated pathways are required to sustain oncogene addiction 233
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study 217
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits 205
Personalized therapeutic strategies in HER2-driven gastric cancer 204
YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC 199
Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies: from basic research to a clinical perspective. 183
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies 171
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts 165
MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors. 164
Istologia Medica 151
The tetraspanin CD151 is required for met-dependent signaling and tumor cell growth 139
Activation of RAS family members confers resistance to ROS1 targeting drugs. 129
Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition. 121
Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort 115
Targeted therapies in cancer and mechanisms of resistance. 114
Targeted therapies for gastric cancer: failures and hopes from clinical trials 105
MicroRNAs impair MET-mediated invasive growth 104
ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells. 81
Cytokine Induced Killer cells immunotherapy overcomes the resistance to MET tyrosine kinase inhibitors in nonsmall cell lung cancer 81
The Semaphorin 4D receptor controls invasive growth by coupling with Met 79
Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility 75
A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer 73
HGF/MET signaling protects Plasmodium infected host cells from apoptosis 65
The landscape of d16HER2 splice variant expression across HER2-positive cancers 65
Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages 62
Semaphorin 4D regulates gonadotropin hormone-releasing Hormone-1 neuronal migration through Plexin B1-Met Complex 61
Optimized EGFR blockade strategies in EGFR addicted gastroesophageal adenocarcinomas 59
Hepatocyte growth factor and its receptor are required for malaria infection 57
Patient-derived cancer models 57
Autocrine signaling of NRP1 ligand galectin-1 elicits resistance to BRAF-targeted therapy in melanoma cells 57
Silencing the MET oncogene leads to regression of experimental tumors and metastases 55
Cancer therapy: can the challenge be MET? 53
Hepatocyte growth factor/met system 53
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers 52
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells. 51
MET overexpression turns human primary osteoblasts into osteosarcomas 51
Sema4D induces angiogenesis through Met recruitment by Plexin B1 49
p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling 48
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling 48
Interplay between scatter factor receptors and B plexins controls invasive growth 46
Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS) 44
Molecularly targeted therapies for gastric cancer. State of the art 42
Increase of MET gene copy number confers resistance to a monovalent MET antibody and establishes drug dependence. 41
HER2 copy number and resistance mechanisms in patients with HER2-positive advanced gastric cancer receiving initial trastuzumab-based therapy in JACOB trial 37
Oncogenes and tumor suppressor genes 32
Microsatellite instability in Gastric Cancer: Between lights and shadows 32
The importance of being CAFs (in cancer resistance to targeted therapies) 29
Patient-Derived Orthotopic Xenograft models in gastric cancer: a systematic review 23
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors 17
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer 10
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models 1
Totale 5.566
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.179
article - articoli 0
book - libri 0
conference - conferenze 242
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.421
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019206 0 0 0 0 0 0 0 0 0 0 142 64
2019/2020924 52 31 47 107 78 196 104 74 90 55 56 34
2020/2021666 39 46 47 76 38 32 90 40 58 58 42 100
2021/20221.096 74 81 86 78 58 45 63 58 48 82 256 167
2022/20231.111 103 97 37 86 131 240 75 63 118 25 76 60
2023/2024498 80 102 31 42 47 64 29 41 21 40 1 0
Totale 5.566